Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pamela N, Peters"'
Autor:
Pamela N. Peters, Regina S. Whitaker, Felicia Lim, Shonagh Russell, Elizabeth A. Bloom, Justin Pollara, Kyle C. Strickland, Mark J. Cantwell, Amer Beg, Andrew Berchuck, Scott Antonia, Rebecca A. Previs
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 57, Iss , Pp 101056- (2024)
Single agent immune checkpoint inhibitors have been ineffective for patients with advanced stage and recurrent high grade serous ovarian cancer (HGSOC). Using pre-clinical models of HGSOC, we evaluated the anti-tumor and immune stimulatory effects of
Externí odkaz:
https://doaj.org/article/6671225534084b968c89f7e95e76d5ae
Publikováno v:
Gynecologic Oncology. 174:247-252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a50dbef62c8fa3add79ea63cdd3d39d
https://doi.org/10.1016/j.ygyno.2023.05.016
https://doi.org/10.1016/j.ygyno.2023.05.016
Autor:
Francisco Grau Bejar, Ana Oaknin, Casey Williamson, Jyoti Mayadev, Pamela N. Peters, Angeles Alvarez Secord, Alyssa M. Wield, Lan G. Coffman
Publikováno v:
American Society of Clinical Oncology Educational Book. :483-499
During the past decade, considerable strides have been made in the understanding and treatment of gynecologic cancers. The advent of PARP inhibitors, antiangiogenic therapies, immunotherapy combinations, and targeted agents have altered the standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e686e41feef3ed5c07c8348bbfe6b1
https://doi.org/10.1200/edbk_351294
https://doi.org/10.1200/edbk_351294
Autor:
Pamela N, Peters, Emma C, Rossi
Publikováno v:
Gynecologic Oncology. 168:A2-A3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45e789bb191b7749d3d52b0f8d1b4330
https://doi.org/10.1016/j.ygyno.2022.12.006
https://doi.org/10.1016/j.ygyno.2022.12.006
Autor:
Shonagh Russell, Felicia Lim, Pamela N. Peters, Suzanne E. Wardell, Regina Whitaker, Ching-Yi Chang, Rebecca A. Previs, Donald P. McDonnell
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4219
Despite advances in surgery and targeted therapies, the prognosis for women with high-grade serous ovarian cancer remains poor. Moreover, unlike other cancers, immunotherapy has minimally impacted outcomes in patients with ovarian cancer. Progress in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44f15667886e7bddf3c2085adfd4a4b0
Autor:
Pamela N. Peters, Julia M. Moyett, Brittany A. Davidson, Sarah Cantrell, Sara E. Bliss, Laura J. Havrilesky
Publikováno v:
Gynecologic oncology. 167(3)
Patients with recurrent platinum-resistant ovarian cancer often present with inoperable malignant bowel obstruction (MBO) from a large burden of abdominal disease. Interventions such as total parenteral nutrition (TPN) and chemotherapy may be used in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e4ce3a2906c182bcc508cdd974bd75
https://pubmed.ncbi.nlm.nih.gov/36344293
https://pubmed.ncbi.nlm.nih.gov/36344293
Autor:
Elizabeth A. Bloom, Pamela N. Peters, Regina Whitaker, Shonagh Russell, Benjamin Albright, Shelly Cummings, Kirsten M. Timms, Thomas Slavin, Braden Probst, Kyle C. Strickland, Rebecca A. Previs
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 528
Background: Uterine serous carcinomas represent 10% of uterine carcinomas but account for nearly 40% of deaths from the disease. Improved molecular characterization of these tumors is instrumental in guiding targeted treatment and improving outcomes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03121f390028f0251db575be44481a53
https://doi.org/10.3390/cancers15020528
https://doi.org/10.3390/cancers15020528
Autor:
Pamela N, Peters, William E, Pierson, Lee-May, Chen, Antonio C, Westphalen, Jocelyn S, Chapman, I-Chow, Hsu
Publikováno v:
Abdominal radiology (New York). 46(1)
We aimed to examine utilization patterns of positron emission tomography scans (PET or PET/CT) beyond 6 months after cervical cancer treatment. We investigated survival outcomes of asymptomatic patients with PET-detected recurrence.We performed a ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d6302b2717cde6938dd751b6492537f
https://pubmed.ncbi.nlm.nih.gov/32638077
https://pubmed.ncbi.nlm.nih.gov/32638077